For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of America’s Fastest-Growing Private Companies

The Latest News from BioAgilytix

18 August, 2021

MicroConstants to Join BioAgilytix Family

Highly complementary transaction strengthens BioAgilytix’s ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientistsDurham, NC, August 18, 2021 –…

Read More

16 August, 2021

BioAgilytix to Purchase Australia-based 360biolabs®

Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographiesDurham, NC, August 16, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused…

Read More

12 July, 2021

BioAgilytix Welcomes Amanda L. Hays, Ph.D. To Team As Scientific Officer

DURHAM, North Carolina – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, welcomes Amanda L. Hays, Ph.D. to its team as Scientific Officer. Dr. Hays will provide consultative…

Read More

8 June, 2021

BioAgilytix Holds Ribbon Cutting to Celebrate Boston Lab Expansion, Additional Jobs and Tech Capabilities

BOSTON, Massachusetts – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, recently held a ribbon-cutting to celebrate the large-scale expansion of its leading-edge Boston laboratory. Located in the…

Read More

15 January, 2021

Carolina Business Review: Panel Interview with BioAgilytix CEO Jim Datin

In this episode of Carolina Business Review, BioAgilytix CEO Jim Datin gets interviewed by PBS Charlotte with the other panel guests Carl Blackstone and Brian Etheridge.

Read More

13 January, 2021

BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

HAMBURG, GERMANY: Jan 13, 2021 – BioAgilytix is thrilled to announce that our European lab in Hamburg, Germany is now CIR approved for 2020, 2021 and 2022, which allows us…

Read More

8 January, 2021

TBJ Covers 2021 People to Watch: BioAgilytix CEO Jim Datin

In this news article, TBJ covers in depth the history and achievements of BioAgilytix’ CEO, Jim Datin. He has been at the helm of BioAgilytix since November 2013 and has…

Read More

19 November, 2020

Jim Datin is Highlighted in TBJ Talking About BioAgilytix’ Performance in 2020 and Beyond

In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’ performance and the challenges they have experienced in 2020.

Read More

30 October, 2020

BioAgilytix Bioanalytical Lab Welcomes the Phadia 200 to Its Hamburg Laboratory

HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With the help of this innovative instrument,…

Read More